Jennifer Baldock, the Chief Administration and Development Officer of Surgery Partners, Inc. (NASDAQ:SGRY), sold 5,681 shares of the company's common stock on February 7, according to a recent filing ...

Build or buy? adding more talent doesn’t equate to performance. It's more effective, and cheaper, to invest in development.

Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron business to Bain Capital, a leading private investment firm. The transaction, valued at $287 million, is expected to close ...

This recent report from The Boyd Company provides a look at operating costs for advanced manufacturing and corporate offices across 60 locations.

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.